Highlights
- Stratos Wealth Partners LTD. reduced its Sanofi holdings by 10.8% in the fourth quarter.
- Institutional investors own 14.04% of Sanofi’s stock.
- Market capitalization stands at $137.02 billion.
Institutional Investments and Market Activity
Sanofi (NASDAQ:SNY), a major entity in the healthcare sector, operates across pharmaceuticals, vaccines, and consumer healthcare. Institutional investors have been actively adjusting their positions in the company, reflecting shifts in market participation. Stratos Wealth Partners LTD. reduced its Sanofi holdings by 10.8% in the fourth quarter, selling 613 shares and retaining 5,057 shares, valued at approximately $244,000.
Other firms have displayed interest in Sanofi. AQR Capital Management LLC added a new position during the second quarter, amounting to $344,000. Creative Planning increased its stake by 18% in the third quarter, now holding 220,763 shares valued at around $12.7 million. These movements highlight varying levels of engagement in Sanofi’s stock.
During the same period, Asset Dedication LLC significantly increased its stake by 284.1%, now holding 3,902 shares valued at $225,000. Probity Advisors Inc. and Mezzasalma Advisors LLC also expanded their holdings, contributing to the overall institutional ownership of 14.04% of Sanofi’s stock.
Financial Metrics and Market Valuation
Sanofi’s stock opened at $53.99 in the most recent session, with a market capitalization of $137.02 billion. The company holds a P/E ratio of 21.68 and a beta of 0.57. Over the past year, its stock price has ranged from $45.22 to $58.97. The company’s liquidity is reflected in its current ratio of 1.46 and quick ratio of 0.74.
Market Movements and Corporate Developments
Institutional activity continues to evolve, with some firms reducing their stakes while others expand their holdings. These shifts indicate ongoing market adjustments and engagement with Sanofi’s stock. The company remains focused on pharmaceutical innovations, vaccine development, and expanding its consumer healthcare segment.
Business Focus and Industry Role
Sanofi is engaged in the research, development, and commercialization of pharmaceutical products. Its operations span multiple regions, serving various healthcare needs. The company continues to play a role in advancing treatments and medical solutions, supporting the broader healthcare industry through its diverse portfolio.